Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing

Fertility and Sterility

Volumn 90, Issue 6, 2008, Pages 2091-2098

  Baker, Valerie L ^a,b   Rone, Heather M ^a   Adamson, Geoffrey David ^a  

^a Fertility Physicians of Northern California   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

genetic testing; Oocyte donation; patient preferences

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DONOR SELECTION; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; MEDICAL INFORMATION; OOCYTE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; CHOICE BEHAVIOR; CYSTIC FIBROSIS; FEMALE; FERTILIZATION IN VITRO; FRAGILE X SYNDROME; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; OOCYTE DONATION; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREIMPLANTATION DIAGNOSIS; PROGRAM EVALUATION; QUESTIONNAIRES; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 56649106312     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.069     Document Type: Article

References (14)

1. American Society for Reproductive Medicine. Minimal genetic screening for gamete donors. Fertil Steril 77 (2002) S15-S16
2. Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology. 2006 guidelines for gamete and embryo donation. Fertil Steril 86 (2006) S38-S50
3. European Society of Human Genetics and European Society of Human Reproduction and Embryology. The need for interaction between assisted reproduction technology and genetics: recommendations of the European Societies of Human Genetics and Human Reproduction and Embryology. Hum Reprod 21 (2006) 1071-1073
4. Schover L.R., Thomas A.J., Falcone T., Attaran M., and Goldberg J. Attitudes about genetic risk of couples undergoing in-vitro fertilization. Hum Reprod 13 (1998) 862-866
5. Hershberger P., Klock S.C., and Barnes R.B. Disclosure decisions among pregnant women who received donor oocytes: a phenomenological study. Fertil Steril 87 (2007) 288-296
6. Zenke U., and Chetkowski R.J. Inclusion of heterozygotes for cystic fibrosis in the egg donor pool. Fertil Steril 78 (2002) 557-561
7. Lewis V., Saller Jr. D.N., Kouides R.W., and Garza J. Survey of genetic screening for oocyte donors. Fertil Steril 71 (1999) 278-281
8. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol 107 (2006) 1483-1485
9. Pastore L.M., Karns L.B., Pinkerton J.V., Silverman L.M., Williams C.D., and Camp T.R. Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction. Am J Obstet Gynecol 194 (2006) 738-743
10. Spence W.C., Black S.H., Fallon L., Maddalena A., Cummings E., Menapace-Drew G., et al. Molecular fragile X screening in normal populations. Am J Med Genet 64 (1996) 181-183
11. Ravel C., Letur H., Lannou D.L., Barthélémy C., Bresson J.L., Siffroi J.P., et al. High incidence of chromosomal abnormalities in oocyte donors. Fertil Steril 87 (2007) 439-441
12. Cryos International. Available at: http://www.cryosinternational.com/donor-semen/screening.aspx. Accessed on March 9, 2007.
13. Carey K.N., and McCartney J. Wrongful life and wrongful birth: legal aspects of failed testing in oocyte donation. Penn Bioeth J 1 (2005) 1-4
14. Roth R. Congenital disabilities and the law. Clin Perinatol 34 (2007) 263-273